Stock Chart
ACLX
$115.07
+0.03%
Score:
49.5
HOLD
LEAPs:
SELL
$110
LEAPs Option Signal
Type: SELL wallstreet
Strike: $110
Premium: $5.10
Expiry: Jan 15, 2027
Target: $111
Score: -79
LEAPs are long-term options (1+ year) with less time decay.
Type: SELL wallstreet
Strike: $110
Premium: $5.10
Expiry: Jan 15, 2027
Target: $111
Score: -79
LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol:
18.01x
(vs SPY: 17.9x | vs QQQ: 17.4x)
Volume Ratio Explained
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Apr 27, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
About ACLX - Arcellx, Inc. Common Stock
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Key Statistics
Market Cap
$7B
More ACLX Analysis
This ACLX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ACLX's price movements with trendlines, gamma walls, and key support/resistance levels.